← Back to Search

Control: electrocautery for Total Knee Replacement

N/A
Waitlist Available
Research Sponsored by Emory University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 weeks, 3 months, 6 months, and 12 months post-operatively.
Awards & highlights

Study Summary

This trial is testing whether two different methods of medial subperiosteal release during total knee arthroplasty (scalpel or electrocautery) have different effects on joint balancing.

Eligible Conditions
  • Total Knee Replacement
  • Osteoarthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 weeks, 3 months, 6 months, and 12 months post-operatively.
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks, 3 months, 6 months, and 12 months post-operatively. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Incidence of Pes bursitis
Change in Oxford Knee Score (OKS)
Change in Visual Analogue Pain Scale (VAS)
Secondary outcome measures
Changes in Varus valgus knee assessment

Trial Design

2Treatment groups
Active Control
Group I: Control: electrocauteryActive Control1 Intervention
Primary patients with Osteoarthritis (OA) undergoing Total Knee arthroplasty (TKA) will be randomly assigned into either the control or investigational group. The control arm of the study will undergo medial sub periosteal release with electrocautery.
Group II: Investigational: sharp dissection.Active Control1 Intervention
Primary patients with OA undergoing TKA will be randomly assigned into either the control or investigational group. The investigational arm will undergo medial sub periosteal release using sharp dissection.

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor
1,647 Previous Clinical Trials
2,564,637 Total Patients Enrolled
~2 spots leftby Jun 2025